AORT Stock Analysis: Buy, Sell, or Hold?
AORT - Artivion, Inc.
$22.47
0.08 (0.36%)
▲
5d:
+8.66%
30d:
+1.26%
90d:
-36.54%
BUY
HIGH Confidence
Analysis Updated: Jun 30, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Get Alerted When AORT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: AORT trading at deep discount. Market pricing in -6.4% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: AORT trading at deep discount. Market pricing in -6.4% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$35.05
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$21.76
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: AORT is currently trading at $22.47, which is considered slightly high relative to its 30-day fair value range of $20.41 to $22.47. From a valuation perspective, the stock is trading at a discount (Forward PE: 31.1) compared to its historical average (38.0). Remarkably, the market is currently pricing in an annual earnings decline of 6.4% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $20.09, while resistance sits at $24.04.
Market Sentiment: AORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+87.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AORT is in a strong downtrend. Immediate support is located at $20.09, while resistance sits at $24.04.
Market Sentiment: AORT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $42.00 (+87.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$20.41 -
$22.47
Company Quality Score
57/100
(HOLD)
Options IV Signal
70th percentile
(ELEVATED)
Volume Confirmation
HIGH
Confidence Score
75.0%
All Signals
- NEUTRAL: Options fairly priced (IV 70th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 87.6% below Wall St target ($42.00)
Trading Range Analysis
30-Day Trading Range
$20.41 -
$22.47
Current vs Trading Range
SLIGHTLY HIGH
Expected Move (7 Days)
±$2.50
(11.1%)
Support & Resistance Levels
Support Level
$20.09
Resistance Level
$24.04
Current Trend
Strong Downtrend
Technical data as of
Jun 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.10
Wall Street Target
$42.00
(+87.6%)
Revenue Growth (YoY)
17.5%
Profit Margin
2.5%
Valuation Discount vs History
-6.4% cheaper
PE vs Historical
31.1 vs 38.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-6.4%
(market-implied from PE analysis)
1-Year Target
$20.96
(-6%)
2-Year Target
$19.62
(-12%)
3-Year Target
$18.36
(-18%)
3-Yr Target (if PE normalizes)
(PE: 31→38)
$22.44
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.1, Growth: 63.0%)
$75.57
(+238%)
Base:
(SPY PE: 21.8, Growth: 63.0%)
$52.93
(+136%)
Bear:
(PE: 18.5, Growth: 63.0%)
$44.99
(+101%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (91x PE), but valuation improves significantly next year (31x PE) as earnings recover.
Trailing PE: 91.32 | Current EPS (TTM): $0.25
Bull Case
$50.23
(+124%)
Analyst growth 100.0%, PE expands to 100.5
Base Case
$45.66
(+104%)
Market implied 100.0%, PE stable at 91.3
Bear Case
$15.52
(-31%)
Severe decline -20.0%, PE contracts to 77.6
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.1 to 38.0
Stabilization Target:
$27.36
(+22.2%)
PE Expansion Potential:
+22.2%
Share & Embed Analysis
Last updated: June 30, 2026 4:16 PM ET
Data refreshes hourly during market hours. Next update: 5:16 PM
Data refreshes hourly during market hours. Next update: 5:16 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AORT showing a specific setup today?
Insider Activity (6 Months)
0
Buys
20
Sells
Net
INSIDERS SELLING
Recent Transactions
Jean F Holloway
SELL
8962 shares
2026-03-04
Marshall S Stanton
SELL
2149 shares
2026-03-03
Lance A Berry
SELL
6316 shares
2026-03-03
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$75 | 56 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$240 | 64 BUY |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$97 | 62 BUY |
Advanced AORT Option Strategies
Professional options setups generated by AI based on today's AORT price and gamma walls.
